Messenger RNA (mRNA) therapeutics show immense promise, but their efficacy is limited by suboptimal protein expression. Here, we present RiboDecode, a deep learning framework that generates mRNA codon sequences for enhanced mRNA translation. RiboDecode introduces several advances, including direct learning from large-scale ribosome profiling data and generative exploration of a large sequence space. In silico analysis demonstrates RiboDecode's robust predictive accuracy for unseen genes and cellular environments. In vitro experiments showed substantial improvements in protein expression, significantly outperforming past methods. In addition, RiboDecode enables mRNA design with consideration of cellular context and demonstrates robust performance across different mRNA formats, including m(1)Ψ-modified and circular mRNAs, an important feature for mRNA therapeutics. In vivo mouse studies showed that optimized influenza hemagglutinin mRNAs induce ten times stronger neutralizing antibody responses against influenza virus compared to the unoptimized sequence. In an optic nerve crush model, optimized nerve growth factor mRNAs achieve equivalent neuroprotection of retinal ganglion cells at one-fifth the dose of the unoptimized sequence. Collectively, RiboDecode represents a paradigm shift from rule-based to a data-driven, context-aware approach for mRNA therapeutic applications, enabling the development of more potent and dose-efficient treatments.
Deep generative optimization of mRNA codon sequences for enhanced mRNA translation and therapeutic efficacy.
阅读:2
作者:Li Yupeng, Wang Fan, Yang Jiaqi, Han Zirong, Chen Linfeng, Jiang Wenbing, Zhou Hao, Li Tong, Tang Zehua, Deng Jianxiang, He Xin, Zha Gaofeng, Hu Zhaoyu, Hu Yong, Wu Linping, Zhan Changyou, Sun Caijun, He Yao, Xie Zhi
| 期刊: | Nature Communications | 影响因子: | 15.700 |
| 时间: | 2025 | 起止号: | 2025 Nov 12; 16(1):9957 |
| doi: | 10.1038/s41467-025-64894-x | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
